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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYOsteoclasts (OCs) originate from themyeloid cell lineage, but the successive steps in their lineage commitment are ill-defined, especially
in humans. To clarify OC origin, we sorted cell populations from pediatric bone marrow (BM) by flow cytometry and assessed their
differentiation potential in vitro. Within the CD11bCD34+c-KIT+ BM cell population, OC-differentiation potential was restricted to
FLT3+ cells and enriched in an IL3 receptor (R)ahigh subset that constituted less than 0.5%of total BM. These IL3Rahigh cells also generated
macrophages (MFs) and dendritic cells (DCs) but lacked granulocyte (GR)-differentiation potential, as demonstrated at the clonal level.
The IL3Ralow subset was re-defined as common progenitor of GR, MF, OC, and DC (GMODP) and gave rise to the IL3Rahigh subset
that was identified as common progenitor of MF, OC, and DC (MODP). Unbiased transcriptome analysis of CD11bCD34+c-KIT+FLT3+
IL3Ralow and IL3Rahigh subsets corroborated our definitions of the GMODP and MODP and their developmental relationship.INTRODUCTION
Osteoclasts (OCs), macrophages (MFs), and dendritic cells
(DCs) are closely related cells of the myeloid lineage (Arai
et al., 1999). Terminally differentiated OCs fuse to form
large, multinucleated cells that resorb bone. OCs differen-
tiate from precursors under influence of RANK ligand (L)
that is produced by bone-forming osteoblasts. Ordinarily,
OCs and osteoblasts thus maintain bone homeostasis in a
balanced interaction (Theill et al., 2002).However, in cancer
andautoimmuneand inflammatorydiseases,OC formation
can be promoted by RANKL-expressing tumor or immune
cells, which facilitates bone metastasis, pathological bone
loss, and remodeling (Walsh et al., 2006). Although OCs
are of key importance, their developmental pathway is
largely unknown as testified by the striking absence of
OCs in most depictions of the hematopoietic tree.
The hematopoietic tree describes the developmental
pathways of all blood cells emanating from the pluripotent
hematopoietic stem cell (HSC). The self-renewing HSC
yields the multipotent progenitor (MPP), which in turn
gives rise to more lineage-restricted, oligopotent precur-
sors. The classical model dictates that the MPP bifurcates
into a common myeloid progenitor (CMP) and a common
lymphoid progenitor (CLP). The CMP in turn would bifur-
cate into the megakaryocyte/erythrocyte progenitor (MEP)
and the granulocyte (GR)/MF progenitor (GMP). GRs,
monocytes/MFs, and DCs were thought to arise down-
stream of the GMP (Weissman and Shizuru, 2008). How-
ever, in an alternative model based on mouse data, the
MPP bifurcates into a precursor with megakaryocyte/984 Stem Cell Reports j Vol. 4 j 984–994 j June 9, 2015 j ª2015 The Authorerythroid potential and one with combined myeloid and
lymphoid potential (Kawamoto et al., 2010). This
myeloid-based model was supported by the identification
of a murine lympho/myeloid precursor (LMPP) devoid of
megakaryocyte/erythroid potential (Adolfsson et al.,
2005). Also in line with the myeloid-based model was the
identification of a human multilymphoid progenitor
(MLP) that gave rise to lymphoid cells,MFs, andDCs (Dou-
latov et al., 2010). ThisMLP replaced theCLP in the scheme
of human hematopoiesis (Doulatov et al., 2012). In the
proposed scenario, both MLP and GMP can yield MFs
and DCs, whereas the GMP can additionally give rise to
GRs (Figure 1A). Findings in humans also supported the ex-
istence of the LMPP (Goardon et al., 2011) and suggested
that it bifurcates into the MLP and the GMP (Go¨rgens
et al., 2013; Figure 1A). Recent data in human also revise
the view on the CMP, in accordance to findings in the
mouse (Kawamoto et al., 2010): the humanMPPwas found
to yield a common erythro-myeloid progenitor (EMP) that
gives rise to theMEP and to a precursor of eosinophilic and
basophilic GRs (EoBP) (Mori et al., 2009; Go¨rgens et al.,
2013). In the revised scheme, the CMP is absent and the
GMP lies downstream of the LMPP (Figure 1A).
The human GMP was found to yield only neutrophils
and not other types of GRs (Go¨rgens et al., 2013). Exactly
how monocytes/MFs and DCs develop downstream of
the GMP is intensely studied both in human and mouse.
In the mouse, a common monocyte/MF/DC progenitor
(MDP) has been proposed. The MDP is thought to give
rise to a common DC progenitor (CDP) that exclusively
forms plasmacytoid and conventional DCs and to as
common monocyte progenitor (cMoP) that exclusively
forms monocytes and MFs (Liu and Nussenzweig, 2010;
Hettinger et al., 2013). In contrast, little attention is paid
to OC development. Seminal studies in the mouse have
demonstrated that OCs, MFs, and DCs derive from a com-
monMF/OC/DC progenitor (MODP) that lies downstream
of the GMP (Arai et al., 1999; Miyamoto et al., 2001), as
confirmed by others (Jacome-Galarza et al., 2013). How-
ever, equivalent findings on the origin of the OC in human
hematopoiesis have thus far not been reported.
We previously examined the fate of OC precursors in
mouse BM. Herein, we confirmed and refined the earlier
definition of the MODP and found a downstream MOP
(Xiao et al., 2013). Using the methodology and cues from
this mouse study, we searched for the MODP in humans
and report it here.RESULTS AND DISCUSSION
OC Precursors Are Enriched in the
CD11bCD34+c-KIT+FLT3+ IL3Rahigh Fraction of
Human BM
To identify human OC precursors, we flow cytometrically
purified bone marrow (BM) populations from healthy pedi-
atric donors (Table S1) and analyzed their differentiation
potential in vitro. As markers, we used presence of CD34
as progenitor marker and, by analogy with the mouse
MODP, presence of c-KIT (CD117) and absence of CD11b
(Arai et al., 1999; Xiao et al., 2013). We also examined
FLT3 (CD135)aspotentialmarker, because it ison themouse
MODP (Figure S1A). The tyrosine kinase receptor FLT3 is
essential for homeostatic DC development (McKenna
et al., 2000). It is expressedon theCDPandonupstreampre-
cursors in the mouse (Liu and Nussenzweig, 2010; Weiss-
man and Shizuru, 2008), where high FLT3 levels distinguish
the mouse LMPP from the MEP (Adolfsson et al., 2005).
Among CD11b BM cells, we identified CD34/lowc-KIT+
(G1), CD34+c-KIT+ (G2), and CD34+c-KIT (G3) popula-
tions, of which G2 and G3 could be separated into FLT3
(a) and FLT3+ (b) subpopulations (Figure 1B). Among
these five populations, only CD34+c-KIT+FLT3+ (G2b) cells
proved to have OC-differentiation potential (Figure S1B).
Mature OCs were identified by positive staining for
tartrate-resistant acid phosphatase (TRAP) and vitronectin
receptor (Figure S1C) and by a multi-nuclear appearance
(Figure 1C).
To narrow down the OC precursor population, we tested
as additional markers c-FMS (alias CSF1R/CD115); the
M-CSF receptor for that is present on the MODP (Arai
et al., 1999) and on designated DC and MF precursors in
the mouse (Liu and Nussenzweig, 2010; Hettinger et al.,
2013). CSF1R mRNA was present in CD34+c-KIT+FLT3+Steprecursor cells (Figure 1D), but we could not detect the pro-
tein at the cell surface (results not shown). We also tested
CD27 that marks the murine MODP (Xiao et al., 2013; Fig-
ure S1A), but it was not synthesized in CD11bCD34+c-
KIT+FLT3+ BM cells (Figure 1D). We next considered
IL3Ra (CD123), because its mRNA was enriched in the
FLT3+ fraction of CD11bCD34+c-KIT+ human BM cells
(Figure 1D) and it discriminates CMP and GMP from MEP
(Mori et al., 2009). IL3Ra cell surface expression separated
CD11bCD34+c-KIT+FLT3+ BM cells into two populations:
70%–80%had an IL3Ralow phenotype and the rest had an
IL3Rahigh phenotype (Figure 1E). These populations corre-
sponded to1.7% and0.5%, respectively, of live, ficolled
BM cells (Figure 1F).
Both precursor populations were negative for a lineage
(Lin) marker set composed of CD2, CD3, CD14, CD16,
CD19, CD56, and CD235a (Figure 1E). They also lacked
CD7 and CD10 (Figure 1D; results not shown) that are ac-
quired at the level of the MLP. They expressed CD38 (Fig-
ure 1G) that is acquired downstream of the MPP (Doulatov
et al., 2010). The LinCD7CD10CD34+CD38+IL3Ralow
human BM population can be divided into a CD45RA+
subset that contains the GMP and a more upstream
CD45RA subset with additional MEP potential (Manz
et al., 2002). CD45RA is also expressed on the MLP, but
not further upstream (Doulatov et al., 2010). Within the
CD11bCD34+c-KIT+FLT3+population, the IL3Rahigh sub-
set was uniformly CD45RA+ and the IL3Ralow subset was
largely CD45RA+ (Figure 1G), suggesting that they resided
at the level of, or downstream from, the GMP or MLP.
The IL3Ralow and IL3Rahigh subsets were tested for OC-dif-
ferentiation potential. Only the IL3Rahigh cells grew out
and formedmulti-nuclear TRAP+OC,whereas IL3Ralow cells
formed lownumbers ofmono-nuclear TRAP+OCs thatwere
apparently less mature (Figures 1H and 1I). We conclude
that human OC-precursor potential is enriched within the
CD11bCD34+c-KIT+FLT3+IL3Rahigh BM population that
is furthermore LinCD7CD10CD38+CD45RA+ and con-
stitutes less than 0.5% of total pediatric BM.
Positioning of the IL3Ralow and IL3Rahigh Subsets of
CD11bCD34+c-KIT+FLT3+ BM Cells Relative to the
GMP and MLP
To determine the position of the IL3Ralow and IL3Rahigh
subsets of CD11bCD34+c-KIT+FLT3+ BM cells relative
to theGMP,we evaluated their potential to formGRs. Inter-
estingly, the IL3Ralow subset abundantly generated GRs,
whereas the IL3Rahigh subset lacked this potential (Figures
2A–2C). To position the IL3Ralow and IL3Rahigh subsets
relative to theMLP, we evaluated their potential to generate
B cells. Neither subset yielded B cells, whereas CD34+c-KIT
cells—which contain CD10+ precursors (results not
shown)—did, which validated the assay (Figure 2D).m Cell Reports j Vol. 4 j 984–994 j June 9, 2015 j ª2015 The Authors 985
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We next examined MF-differentiation potential. The
IL3Rahigh subset was more efficient at MF formation than
the IL3Ralow subset (Figures 2E–2G). When plated at
1,000 cells per well, the IL3Rahigh subset generated 7,000–
10,000 cells over 14 days (Figure 2F), most of which were
MFs as indicated by aCD14+CD68+ phenotype (Figure 2G).
Yield from IL3Ralow precursors tended to be lower (Figures
2F and 2G). The difference was not statistically significant
but consistent for multiple BM samples in 8- or 14-day
cultures (data not shown).
To examine DC-differentiation potential, the IL3Ralow
and IL3Rahigh subsets were cultured with M-CSF and
FLT3L. After 8 or 14 days of culture, the IL3Ralow subset
generated more offspring than the IL3Rahigh subset (Fig-
ures 2H and 2I). However, the IL3Rahigh subset was signifi-
cantly more efficient at generating CD11c+ HLA-DR+ cells
than the IL3Ralow subset in the time frame of culture (Fig-
ure 2I). Within the CD11c+ HLA-DR+ population, CD1c
(BDCA-1) and CD141 (BDCA-3) were expressed that are
proposed markers of conventional (c)DCs (MacDonald
et al., 2002; Figure 2J). CD303 (BDCA-2) that is a marker
for plasmacytoid (p)DCs (MacDonald et al., 2002) was
not detected (data not shown).
Our data argue that, among CD11bCD34+c-KIT+FLT3+
human BM cells, the IL3Ra expression level discriminates
two successive stages in commitment toward the OC,
MF, and DC fate. The IL3Ralow subset defines the GMP
(Manz et al., 2002), but we propose that this subset
should be re-defined as GR, MF, OC, and DC progenitor
(GMODP). The IL3Rahigh subset is candidate for the down-
stream, newly defined human MODP.
Validation of the IL3Ralow and IL3ahigh Subsets as
GMODPandMODPbyRefinedAnalysis of DC andMF
Offspring and Clonal Analysis of Oligopotency
To validate that the IL3Rahigh subset of CD11bCD34+c-
KIT+FLT3+ BM cells qualified as DC progenitor, we analyzedFigure 1. Identification of OC Progenitors in Human BM
(A) Proposed models of hematopoietic development, as based on Doula
proposed by us.
(B) Gating strategy for sorting of the live, CD11b G1, G2a and b, an
(C) Light microscopic image showing TRAP+ multi-nuclear OC derived
(D) RT-PCR-based mRNA expression of the indicated genes defined i
BM cells.
(E) Gating for sorting live (PI), IL3Ralow, and IL3Rahigh CD11bCD3
(F) The contribution (%) of the subsets to the total number of live c
(G) Flow cytometric detection of the indicated markers on the IL3
representative of three donors.
(H and I) OC differentiation of IL3Ralow and IL3Rahigh subsets was an
(#) per well of (left) all TRAP+ cells and (right) TRAP+ cells with more
phenotypic appearance of TRAP-stained OC cultures was determined b
staining.
See also Figure S1.
Stethe offspring withmore-specificmarkers for DCs, using the
study by Balan et al. (2014) as a guideline. These authors
recently proved able to derive XCR1+ DCs from human
CD34+ cord blood cells, using a cytokine cocktail and a
feeder cell layer. Importantly, they showed by transcrip-
tome analysis that these DCs were highly similar to
primary XCR1+ DCs from blood and distinct from mono-
cyte-derived DCs. The CD34+ cells in culture also generated
XCR1DCs that were similar to monocyte-derived DCs. In
a side-by-side comparison, we found that MF and DC cul-
tures from IL3Rahigh subset contained similar amounts of
CD11b+ HLA-DR+ cells and that virtually all cells in both
cultures expressed CD141 (Figure S2A). XCR1- and
Clec9a-expressing cells were clearly enriched in the DC cul-
ture as compared to the MF culture (Figure 3A). This agrees
with Balan et al. (2014), who identified XCR1 and Clec9a,
but not CD141, as markers that discriminate between pro-
genitor-derived DCs and monocyte-derived DCs. The DC
culture contained more XCR1+Clec9a+ cells than the MF
culture (Figure 3B), and these cells were enriched for the
DC markers FLT3 and CD1c. In the MF culture,
XCR1+Clec9a+ cells were enriched for the MF marker
CD14high (Figure 3B). The XCR1Clec9a cells in the DC
culture also differed from those in the MF culture (Fig-
ure 3C). In the DC culture, a large proportion of
XCR1Clec9a expressed the DC markers FLT3 and/or
CD1c, but this was not the case in the MF culture. More-
over, in the MF culture, the XCR1Clec9a cells were uni-
formly CD14high, but this was not the case in the DC cul-
ture. Furthermore, the discriminatory monocyte/MF
marker FCGR2A (Balan et al., 2014) was enriched in the
MF cultures as compared to the DC cultures (Figure S2B),
and cells from the MF cultures had a much greater ability
to phagocytose beads than cells from the DC cultures (Fig-
ure S2C). Thus, the IL3ahigh subset gives rise to distinct
progenies underDC- versusMF-differentiation conditions,
arguing that it is a common progenitor for DCs and MFs.tov et al. (2012) (left) and Go¨rgens et al. (2013) (right). OC origin is
d G3a and b populations from ficolled BM.
from the G2b population.
n the FLT3 (G2a) and FLT3+ (G2b) subsets of CD11bCD34+c-KIT+
4+c-KIT+FLT3+ cells from ficolled BM and lineage marker analysis.
ells in ficolled BM (mean + SEM; seven donors).
Ralow and IL3Rahigh subsets (Ctrl, unstained IL3Ralow samples),
alyzed at days 7–9. (H) OC differentiation was quantified as number
than three nuclei (mean + SEM; five donors; ***p < 0.001). (I) The
y CCD microscopy. Green, DAPI staining of nuclei; gray/black, TRAP
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Figure 2. Positioning of the IL3Ralow and IL3Rahigh CD11bCD34+c-KIT+FLT3+ BM Subsets Relative to the GMP and MLP
The IL3Ralow and IL3Rahigh subsets of CD11bCD34+c-KIT+FLT3+ BM cells were sorted and cultured at 1,000 cells/well to determine GR-,
B-cell-, MF-, and DC-differentiation potential.
(A–C) GR differentiation was analyzed at day 14. (A) Appearance of cultures was determined by light microscopy. (B) Absolute number (#)
of live (PI) GRs was determined by flow cytometry based on CD66b expression (mean + SEM; five donors). (C) Representative diagnosis of
CD66b expression is depicted (SS, side scatter).
(D) B cell differentiation. After 3 to 4 weeks of culture, B cells were defined by flow cytometric detection of CD19. Sorted CD34+c-KIT cells
were cultured as a positive control. Data are representative of seven donors.
(E–G) MF differentiation was analyzed at day 14. (E) Appearance of cultures was determined by light microscopy. (F) Absolute number (#)
of cells in culture and frequency (%) of CD14+CD68+ cells was determined by flow cytometry (mean + SEM; five donors). (G) Representative
diagnosis of CD14 and CD68 expression is depicted.
(legend continued on next page)
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Oligopotency of the progenitors was tested in clonogenic
assays. Fromthe IL3Ralow subset, butnot fromthe IL3Rahigh
subset, single cells could be expanded with cytokines on a
mesenchymal stem cell layer (Figure 3D). The offspring of
a single IL3Ralow progenitor could generate MFs, OCs, or
DCs, under the respective differentiation conditions (Fig-
ure 3E), indicating itsmulti-lineage potential.When plated
as single cells directly after sorting, the IL3Ralow subset
yielded MFs, DCs, and GRs, whereas the IL3Rahigh subset
gave rise to MFs and DCs, but not GRs (Figures S2D and
S2E). OCs did not emerge in either situation, presumably
because of the demanding single-cell culture. The single-
cell cultures also did not yield B cells, as expected from
the results of the bulk cultures (Figure S2D). Our data argue
that, among CD11bCD34+c-KIT+FLT3+ human BM cells,
the IL3Ra expression level discriminates between two suc-
cessive stages in commitment toward MF, OC, and DC dif-
ferentiation. The IL3Ralow subset of this BM population
constitutes the GMODP, oligopotent for GR, MF, OC, and
DC differentiation. The IL3Rahigh subset lies downstream
from the GMODP and constitutes the newly identified
MODP, which is oligopotent for MF, OC, and DC differen-
tiation (Graphical Abstract).
mRNA Deep Sequencing Supports the Proposed
GMODP-MODP Relationship between the IL3Ralow
and IL3Rahigh Subsets of CD11bCD34+c-KIT+FLT3+
BM Cells
To further define the IL3Rahigh and IL3Ralow subsets and
their relationship, we compared their gene-expression pro-
files. The transcriptome of 10,000–20,000 cells per sample
(n = 3) was successfully determined by mRNA deep
sequencing. Analysis of all protein-coding genes showed
that the IL3Rahigh samples clustered together, as did the IL3-
Ralow samples (Figure 4A). This confirmed the discrimina-
tory potential of the IL3Ra marker. At p < 0.001, 649 pro-
tein-coding genes were differentially expressed between
the two subsets, indicating their close relationship but
distinctnature.Among these,97geneswith thehighest level
of differential expression were used tomake a heatmap that
specifies the distinct nature of the two subsets (Figure 4B).
Furthermore, the 649 differentially expressed protein-cod-
ing genes were analyzed by ingenuity pathway analysis
(IPA). Gene clusters upregulated in the IL3Rahigh subset
included the functional categories ‘‘differentiation of
MFs,’’ ‘‘differentiation of OCs,’’ and ‘‘differentiation of
antigen-presenting cells’’ (Figure 4C), indicating a further
commitment to MF/OC/DC differentiation in the transi-(H–J) DC differentiation was analyzed at day 8 or 14. (H) Appearance o
number (#) of live cells and frequency (%) of CD11c+ HLA-DR+ cells w
0.001). (J) Representative diagnosis is depicted of CD11c and HLA-DR
DR+ gate.
Stetion from the IL3Ralow to the IL3Rahigh phenotype. Gene
clusters downregulated in the IL3Rahigh subset included
the functional categories ‘‘differentiationofB lymphocytes,’’
‘‘quantity of granulocytes,’’ and ‘‘quantity of eosinophils,’’
consistent with differentiation away from the GR fate (Fig-
ure 4C). In addition, a gene cluster denoting ‘‘differentiation
of cells’’ was upregulated and a gene cluster denoting ‘‘prolif-
eration of hematopoietic progenitor cells’’ was downregu-
lated, in accordance with further commitment to a differen-
tiated cell fate (Figure 4C). The IL3Rahigh subset showed
higher mRNA expression of transcription factors important
for pDC, cDC, and MF development, including SPIB, IRF4,
IRF8, SPI1/PU.1, and ID2 (Figures 4C and 4D; Belz and
Nutt, 2012; Lawrence and Natoli, 2011; Rosenbauer and
Tenen, 2007). This indicated that both pDC and cDC devel-
opmental capacity is contained within the human MODP.
Furthermore, in the IL3Rahigh subset,CSF1Rwasupregulated
(Figure 4D), as well as OSCAR, TYROBP (DAP12), and SYK
(Figure 4C), a membrane receptor and signaling molecules
that drive OC differentiation (Takayanagi, 2007). Both IL3-
Rahigh and IL3Ralow precursor populations expressedmyelo-
peroxidase (MPO) that isdiagnostic for theGMP(Manzetal.,
2002) at similarly high levels (Figure 4D). Collectively, these
deep-sequencing data strongly support, in an unbiased
fashion, our phenotypic and functional definitions of the
human GMODP andMODP.
Whereas this paper was in the final stage of revision, Lee
et al. (2015) published on the origin of DCs and MFs in
human hematopoiesis. In human cord blood, they sepa-
rated the CD34+CD38highCD45RA+CD10 cell population
into IL3Raint and IL3Rahigh subsets that were both FLT3
positive. Within the IL3Raint subset, they re-defined a
CD115CD116 population as GMDP, i.e., a precursor
that has DC-differentiation potential in addition to previ-
ously determined GR- and MF-differentiation potential.
We show that the CD11bCD34+c-KIT+FLT3+ population
in pediatric BM is LinCD38+CD45RA+CD10, and we
also find no CD115 (c-FMS/CSFR1) on the cell surface of
the IL3Ralow subset of this population. Thus, we agree on
the identity of the GMDP and reveal that it is in fact a
GMODP. Furthermore, Lee et al. (2015) defined within
the IL3Raint subset a CD115+CD116 population as MDP,
i.e., a precursor that can give rise to DCs and MFs, but
not GRs. The CD115IL3Rahigh subset was defined as
CDP, i.e., a dedicated common precursor of cDC and
pDC. In absence of a direct comparison of the cord blood
and pediatric BM populations, we cannot exactly match
the proposedMDP and CDP to ourMODP. Both cord bloodf cultures was determined by light microscopy at day 8. (I) Absolute
as determined by flow cytometry (mean + SEM; five donors; ***p <
within the live-cell gate and CD1c and CD141 within the CD11c+HLA-
m Cell Reports j Vol. 4 j 984–994 j June 9, 2015 j ª2015 The Authors 989
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populations should be tested for OC potential. Also, the
CDP population should be tested for MF-differentiation
potential with M-CSF, because only GM-CSF was used.
Nevertheless, we fully agree that an M(O)DP exists down-
stream of the GM(O)DP. Lee et al. (2015) proved both
pDC and cDC potential of their precursors by deep
sequencing of culture-derived and primary cells, support-
ing the commonDCpotential revealed by deep sequencing
in ourMODP. Future work should address the functionality
of the culture-derived cells. Also, additional markers must
be found to discern the MODP and proposed CDP. Under-
standing the development ofOC, DC, andMF is important
for clinical diagnostics, targeted drug-based therapy, and
cellular therapy. Identification of the MODP will also facil-
itate generation of these cell types, with precursor stemness
benefitting expansion and cell yield.EXPERIMENTAL PROCEDURES
Human BM and Flow Cytometry
BMwas obtained from healthy children that were donors for their
sibling, with approval of the medical ethical committee of Leiden
University Medical School (protocol P08.001) and with parental
informed consent. BMmono-nuclear cells were isolated by density
gradient centrifugation on Ficoll and cryopreserved until use. Cells
were stainedwith antibodies inmediumwith 2%FCS. Prior to sort-
ing, 0.01% deoxyribonuclease I was added to prevent cell clump-
ing and 1 mg/ml propidium iodide (Sigma-Aldrich) to exclude
dead cells. Cells were sorted on a FACSAria and analyzed on an
LSRFortessa (BD Biosciences) or CyAn (Beckman Coulter Geno-
mics). Data were analyzed with FloJo software. For mAbs used for
flow cytometry, see Table S2.
In Vitro Differentiation Cultures
In in vitro differentiation cultures, 1,000 sorted precursor cells
were cultured per well in 96-well plates (BD Falcon). Culture con-
ditions were as follows: (1) OC differentiation: 7–9 days in 200 ml
of MEM-a with 10% FCS, 25 ng/ml recombinant human (rh)
M-CSF, and 40 ng/ml rh RANKL. (2) DC differentiation: 8 or
14 days in IMDM with 10% FCS, 25 ng/ml rh M-CSF, andFigure 3. Validation of the IL3Ralow and IL3Rahigh Subsets as GM
(A–C) Sorted IL3RahighCD11bCD34+c-KIT+FLT3+ BM cells were cultu
analyzed by flow cytometry on day 12. Data are representative of two
CD11b+HLA-DR+ cells from MF (blue line) or DC (red line) cultures. Gre
(B and C) Within gated CD11b+HLA-DR+ cells, XCR1+Clec9a+ (B) and XCR
panels) and analyzed for indicated markers.
(D and E) Clonal analysis of oligopotency. IL3Ralow and IL3Rahigh subse
on a mesenchymal stem cell layer for 7–10 days (expansion culture). (
seeded (mean + SEM; two donors). (E) Expansion cultures were split in
OC-, or DC-differentiation conditions. (I) Colony from IL3Ralow subset
generated were visualized by fluorescence microscopy. Blue/turquois
CD14 (MF); gray/black, TRAP (OC).
See also Figure S2.
Ste200 ng/ml rh FLT3L (and 10 ng/ml IL-3 for the experiment de-
picted in Figures 3A–3C). For MF-, GR-, and B-cell differentiation,
cells were cultured on a monolayer of OP9 cells. (3) MF differenti-
ation: 8 or 14 days in IMDM with 10% FCS, 25 ng/ml rh M-CSF,
and 1,000 U/ml rh IL-6 (Chomarat et al., 2000). (4) GR differenti-
ation: 14 days in IMDM with 10% FCS and 100 ng/ml rh G-CSF
(Choi et al., 2009). (5) B-cell differentiation: 3 to 4 weeks in
RPMI-1640 with 10% FCS and 15 ng/ml rh IL-7 (Miltenyi Biotech;
Vieira and Cumano, 2004). For clonogenic assays, cells were sorted
at one cell per well and either pre-expanded in IMDM with 10%
FCS and 5 ng/ml SCF, 10 ng/ml TPO, 5 ng/ml M-CSF, and
20 ng/ml Flt3L on a mesenchymal stem cell layer (Xiao et al.,
2013) or cultured directly. Growth factors were from R&D Systems
unless otherwise indicated. For analysis of cell differentiation, see
Supplemental Information.
RNA Deep Sequencing and PCR
For mRNA deep sequencing, 10,000–40,000 precursors were flow
cytometrically sorted, dissolved in Trizol reagent (Ambion), and
delivered to the NKI Genomics Core Facility. Here, mRNA was iso-
lated and deep sequencing was performed using a HiSeq200 (Illu-
mina). Sequence reads were aligned with TopHat software to the
Ensembl gene set Homo sapiens GRCh37.66. Reads were counted
using htseq-count software. Hierarchical clustering was done in R
and uses 1-correlation as the distance function. Reads for pro-
tein-coding genes were normalized and analyzed for differential
expression using R package limma. The heatmapwas generated us-
ing Qlucore Omics Explorer software (Qlucore). For real-time (RT)
and/or quantitative (q) PCR, RNA was isolated using the RNeasy
Mini Kit (QIAGEN) and treated with DNase I (QIAGEN) to remove
genomic DNA. Next, cDNA was prepared on a Peltier Thermal
Cycler (BioRad), using SuperScript II reverse transcriptase (Invitro-
gen), and either RT-PCR or qPCR was performed with the primers
listed in Table S3. See Supplemental Information for further details.
Statistical Analysis
See Supplemental Information.
ACCESSION NUMBERS
The GEO accession number for the data reported in this paper is
GSE65996.ODP and MODP
red side by side under MF- or DC-differentiation conditions and
donors. (A) Indicated marker expression was determined in gated
y lines depict controls (Ctrl), unstained samples from the DC culture.
1Clec9a (C) populations were further gated (red boxes in the left
ts were cultured at one cell per well with SCF, TPO, M-CSF, and FLT3L
D) Percentage of wells with a colony was determined out of 48 wells
to three equal fractions and further cultured for 7 days under MF-,
in expansion culture was analyzed by light microscopy. (II–IV) Cells
e, nuclear staining by DAPI; green, CD68 (MF) or CD11c (DC); red,
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Figure 4. Transcriptomics Validates the Functional Definition of IL3Rahigh and IL3Ralow CD11bCD34+c-KIT+FLT3+ BM Subsets and
Their Relationship
IL3Rahigh and IL3Ralow subsets were sorted from BM of donors III, VI, and VII and subjected to mRNA deep sequencing. Sequence reads
were analyzed as indicated in the Supplemental Information.
(A) Hierarchical clustering of all protein-coding genes from the different samples.
(B) Heatmap, made with Qlucore software including 97 genes with the highest differential expression (p < 0.001; log2-fold change > 3.5
or <3.5). Upregulated and downregulated genes are ordered separately according to the degree of differential expression (from ‘‘high’’ to
‘‘low’’). The scale bar denotes expression level as log2 value.
(C) Results are depicted of IPA of 649 genes found to be differentially expressed at p < 0.001. The IPA network: extracellular, plasma
membrane, cytoplasmic, and nuclear molecules with higher mRNA expression in the IL3Rahigh subset are depicted in shades of red (positive
log2 ratios) and molecules with lower mRNA expression in shades of green (negative log2 ratios). The molecules depicted cluster in the
listed functional categories of genes as identified by IPA.
(D) Validation of a selection of molecules by qPCR on mRNA (mean + SEM; three donors).
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